Analysts Issue Forecasts for TG Therapeutics FY2025 Earnings
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2025 earnings estimates for TG Therapeutics in a report issued on Tuesday, May 6th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the biopharmaceutical company will earn $0.58 per share for the year, down from their previous estimate of $1.08. […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2025 earnings estimates for TG Therapeutics in a report issued on Tuesday, May 6th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the biopharmaceutical company will earn $0.58 per share for the year, down from their previous estimate of $1.08. […]
